Evidence map›Paper›PMID 29168874›Full record

ArticleIntegrative biology : quantitative biosciences from nano to macro2017

Bioreactor model of neuromuscular junction with electrical stimulation for pharmacological potency testing.

Surapon N Charoensook, Damian J Williams, Syandan Chakraborty, Kam W Leong, Gordana Vunjak-Novakovic

Abstract read
In one paragraph

Article in Integrative biology : quantitative biosciences from nano to macro, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Advances in Engineering Human Tissue Models.Frontiers in bioengineering and biotechnology · 2020
    Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Optimization of Application-Driven Development ofTissue engineering. Part B, Reviews · 2022
    Review
  9. Review
  10. Neuromuscular disease modeling on a chip.Disease models & mechanisms · 2020
    Review
  11. Review
  12. Botulinum Toxin Type A Possibly Affects CaDrug design, development and therapy · 2020
    Article
  13. Review
  14. Challenges and Future Prospects on 3DFrontiers in bioengineering and biotechnology · 2018
    Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Surapon N CharoensookDepartment of Biomedical Engineering, Columbia University, 622 West 168th Street, VC12-234, New York, NY 10032, USA. gv2131@columbia.edu.
Damian J Williams
Syandan Chakraborty
Kam W Leong
Gordana Vunjak-Novakovic
Columbia University Irving Medical Center · USIn-Q-Tel · US

Funding

Translational Bioreactors - Engineering Complex TissuesP41EB002520 · NIBIB · TUFTS UNIVERSITY MEDFORD · PI KAPLAN, DAVID L. · 2004 to 2018
$16.7M
NIBIB NIH HHS P41 EB002520
6 · The paper itself

Abstract

In vitro models of the neuromuscular junction (NMJ) are emerging as a valuable tool to study synaptogenesis, synaptic maintenance, and pathogenesis of neurodegenerative diseases. Many models have previously been developed using a variety of cell sources for skeletal muscle and motoneurons. These models can advanced by integrating beneficial features of the native developmental milieu of the NMJ. We created a functional in vitro model of NMJ by bioreactor cultivation of transdifferentiated myocytes and stem cell-derived motoneurons, in the presence of electrical stimulation. In conjunction with a coculture medium, electrical stimulation resulted in improved maturation and function of motoneurons and myocytes, as evidenced by mature cellular structures, increased expression of neuronal and muscular genes, clusterization of acetylcholine receptors (AChRs) in the vicinity of motoneurons, and the response to glutamate stimulation. To validate the model and demonstrate its utility for pharmacological testing, we documented the potency of drugs that affect key pathways during NMJ signal transduction: (i) acetylcholine (ACh) synthesis, (ii) ACh vesicular storage, (iii) ACh synaptic release, (iv) AChR activation, and (v) ACh inactivation in the synaptic cleft. The model properly responded to the drugs in a concentration-dependent manner. We thus propose that this in vitro model of NMJ could be used as a platform in pharmacological screening and controlled studies of neuromuscular diseases.

Indexed as

BioreactorsAnimalsCell SeparationCoculture TechniquesDose-Response Relationship, DrugDrug Evaluation, PreclinicalElectric StimulationGlutamic AcidGreen Fluorescent ProteinsMagneticsMiceMotor NeuronsMuscle CellsNeuromuscular JunctionStem CellsGlutamic AcidGreen Fluorescent Proteins

Identifiers

PMID29168874
PMCPMC5725265
OpenAlexW2768902437

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.